Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 17, 2022

Total Value ($000): $290,135 (100.0% shares, 0.0% debt)

Holdings (13)

REGN REGENERON PHARMACEUTICALS 16.1%
Value ($000) $46,710 Shares 66,880 Est. Cost $342.96 Unrealized +83.4%
ENTA ENANTA PHARMACEUTICALS INC 13.5%
Value ($000) $39,066 Shares 548,828 Est. Cost $44.67 Unrealized +45.7%
MCK MCKESSON CORP 13.1%
Value ($000) $38,011 Shares 124,165 Est. Cost $138.18 Unrealized +92.9%
ALKS ALKERMES PLC 12.9%
Value ($000) $37,471 Shares 1,424,204 Est. Cost $18.73 Unrealized +32.2%
UTHR UNITED THERAPEUTICS CORP 12.5%
Value ($000) $36,171 Shares 201,612 Est. Cost $121.76 Unrealized +56.5%
EXEL EXELIXIS INC 12.0%
Value ($000) $34,694 Shares 1,530,406 Est. Cost $18.77 Unrealized +4.0%
— TARO PHARMACEUTICAL INDUS 8.4%
Value ($000) $24,483 Shares 565,951 Est. Cost $76.45 Unrealized —
BIIB BIOGEN INC 8.1%
Value ($000) $23,451 Shares 111,353 Est. Cost $304.93 Unrealized -28.7%
EGRX EAGLE PHARMACEUTICALS INC 2.0%
Value ($000) $5,681 Shares 114,787 Est. Cost $44.28 Unrealized +8.4%
KOD KODIAK SCIENCES INC 1.2%
Value ($000) $3,479 Shares 450,600 Est. Cost $39.02 Unrealized 0.0%
CAH CARDINAL HEALTH INC 0.3%
Value ($000) $748 Shares 13,200 Est. Cost $49.18 Unrealized 0.0%
— NEXTCURE INC 0.1%
Value ($000) $149 Shares 30,591 Est. Cost $9.95 Unrealized —
— ASSEMBLY BIOSCIENCES INC 0.0%
Value ($000) $21 Shares 10,100 Est. Cost $2.08 Unrealized —